Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
Filter results
You can narrow down the results using the filters
Topic
- Medical devices (59)
- Scheduling (52)
- OTC medicines (12)
- Prescription medicines (8)
- Complementary medicines (7)
- Labelling and packaging (4)
- Legislation (4)
- Medicines (4)
- Advertising (3)
- Advisory bodies and committees (3)
- Biologicals (3)
- Therapeutic goods regulation (3)
- Fees and payments (2)
- Listed medicines (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Clinical trials (1)
- Import and export (1)
- Manufacturing (1)
- Medical devices safety (1)
- Medicinal cannabis hub (1)
- Medicines safety (1)
- Nicotine vaping products hub (1)
- Other therapeutic goods (1)
- Safety (1)
- Sunscreens (1)
- Unique Device Identification (UDI) Hub (1)
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Read the details of recent consultations, submissions and decisions at the TGA Consultation hub.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Search
188 result(s) found, displaying 1 to 25
- Closed onConsultationConsultation: TGA Fees and Charges Proposal 2023-24The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2023-24 financial year. Closing date: 20 March 2023
- Closed onConsultationConsultation: Seeking feedback on improvements to the recalls processThe TGA is seeking feedback on improvements to the therapeutic goods recalls process. Closing 13 March 2023.
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACMS, ACCS and joint ACMS-ACCS meetings, March 2023Proposed amendments to the Poisons Standard. Closing date: 3 February 2023
- Closed onConsultationConsultation: Proposed reforms to the regulation of nicotine vaping productsThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products (NVPs) in Australia.
- Closed onConsultationConsultation: International harmonisation of ingredient names (IHIN) – Dual labelling transition to sole medicine ingredient namesThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.
- Closed onConsultationConsultation: Draft Guidance: Boundary and Combination products - medicines, medical devices and biologicalsThe TGA is seeking feedback on the draft guidance ‘Boundary and combination products - medicines, medical devices, and biologicals’.
- Closed onConsultationConsultation: Adoption of International Scientific Guidelines in AustraliaThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted.
- Closed onConsultationConsultation: Regulatory options to potentially allow references to the TGA in therapeutic goods advertisingThe TGA is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard in relation to paracetamol - ACMS meeting, November 2022Closing date: 14 October 2022
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard – ACCS, ACMS and joint ACCS/ACMS meetings, November 2022Proposed amendments to the Poisons Standard. Closing date: 29 September 2022
- Closed onConsultationConsultation: Detailed considerations for implementing the proposed Australian medical device UDI regulatory frameworkThe TGA is seeking feedback on the third consultation paper published by the TGA relating to the Australian implementation of a Unique Device Identification (UDI) System for medical devices.
- Closed onConsultationConsultation: Product Information as a package insert in boxed injectablesPublic consultation on the Product Information (PI) as a package insert in boxed injectable products.
- Closed onConsultationConsultation on proposed regulatory changes for clinical trials of medical devicesThe (TGA) is seeking feedback on proposed regulatory changes to strengthen safety oversight of clinical trials for medical devices.
- Closed onConsultationConsultation: 2022-2023 Proposed changes to the Permissible Ingredients Determination - Low-negligible riskClosed: 15 September 2022. Consultation results are now available on the TGA Consultation Hub
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, June 2022Proposed amendments to the Poisons Standard. Closing date: 27 May 2022
- Closed onConsultationConsultation: Repurposing of medicinesConsultation seeking feedback on the repurposing of medicines to inform the development of options for Government consideration closed 1 April 2022
- Closed onConsultationConsultation: Proposed update to the evidence guidelines for listed medicinesThe TGA is seeking feedback on the updated 'Listed medicines evidence guidelines - How to demonstrate efficacy of listed medicines'. Closing date: 1 April 2022
- Closed onConsultationConsultation: Priority Review pathway for biologicals: feasibility, potential eligibility criteria and determination processThe TGA is seeking feedback on a proposed priority pathway for assessment of certain novel and life-saving biologicals. Closing date: 28 March 2022
- Closed onConsultationConsultation: Fees and Charges Proposal 2022-23The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2022-23 financial year. Closing date: 7 March 2022
- Closed onConsultationConsultation: Improving access to medicine adverse event data - sponsor surveyThe TGA is seeking feedback from sponsors on improving their access to medicine adverse event data. Closing date 18 February 2022
- Closed onConsultationConsultation: Adoption of International Scientific Guidelines in AustraliaThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted. Closing date: 20 February 2022
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, March 2022Proposed amendments to the Poisons Standard. Closing date: 31 January 2022
- Closed onConsultationConsultation on Extemporaneous Compounding of Emergency MedicinesThe TGA is seeking feedback on a proposal to improve patient access to critical medicines in acute-care settings. Closing date: 7 February 2022
- Closed onConsultationConsultation on potential regulatory options for 'export only' biologicalsThe TGA is conducting a public consultation on potential options for the regulation of biologicals manufactured in Australia for export only (and not for supply in Australia). Closing date: 20 December 2021
- Closed onConsultationDiscussion paper on potential for mandatory reporting of medical device adverse events by healthcare facilities in AustraliaThe TGA sought feedback on a Discussion paper on potential changes to mandatory reporting of medical device adverse events.